Owing to recent advances in early reperfusion strategies, pharmacological therapy,
standardized care, and the identification of vulnerable patient subsets, the prognosis of …

Introduction Aortic valve stenosis (AS) is present in up to 10% of individuals over age 80
years. Transcatheter aortic valve replacement (TAVR) has become the most common …

In recent years, transcatheter aortic valve replacement (TAVR) has become the leading
method for treating aortic stenosis. While the procedure has improved dramatically in the …

Background Among patients with acute coronary syndrome following transcatheter aortic
valve replacement (TAVR), those presenting with ST-segment elevation myocardial …

Background: The supra-annular leaflet position and tall stent frame of the self-expanding
Evolut PRO or Evolut PRO+ transcatheter heart valves (THVs) may cause coronary …

Objectives The aim of this study was to characterize the feasibility of coronary angiography
(CA) and percutaneous coronary intervention (PCI) in acute settings among patients who …

Periprocedural systemic embolism is a well-documented complication of transcatheter aortic
valve replacement (TAVR). Although the most focus was given to cerebral embolism (which …

Background Coronary access after transcatheter aortic valve implantation (TAVI) with supra-
annular self-expandable valves may be challenging or un-feasible. There is little data …

Heart disease is a significant health concern for elderly individuals, with heart aging being
the primary cause. Recent studies have shown that autophagy can play a protective role in …

Transcatheter aortic valve implantation (TAVR) is the first therapeutic option for elderly
patients with severe symptomatic aortic stenosis, and indications are steadily expanding to …